From: Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma
Practice | Statement | References |
---|---|---|
Preoperative work-up | ||
Biopsy | A full thickness or in minimum incisional biopsy, request histological analysis for sebaceous cancer. | [13] |
Biopsy in chalazion surgery | Request histological analysis, when the lesion is clinically suspicious or recurrent. | [13] |
Preoperative conjunctival mapping biopsies | Consider, if there is suspected conjunctival involvement. | |
Regional lymph node scanning | Offer for category T2b (AJCC 7-th edition) or T2c (AJCC 8th- edition) and worse. | |
Colonoscopy | Should preferably be offered for all patients with sebaceous cancer. 1) | |
A genetic counseling for Muir-Torre syndrome | Should preferably be offered if: • two or more primary sebaceous tumours in one patient and/or • under 60 years old and history of another MTS or Lynch cancer (colon, rectum, endometrial, ovarian, small bowel, gastric, urinary tract and brain) and/or • under 60 years old and at least one first degree relative with a tumour above. 2) | [24] |
Treatment | ||
Primary treatment method | Surgery with posterior lamellar resection. | |
Clinical margin | At least 4–5 mm. 3) | |
Method of surgery | Multi-stage resection with delayed closure, frozen sections or Mohs surgery are recommended to verify tumour-free margins. Conjunctival mapping biopsies can be performed together with the final surgery if performed as multi-stage resection with delayed closure. | |
Sentinel lymph node biopsies | SLNB could be considered for tumours larger than 10 mm. | |
PET/CT | PET/CT could be considered in the initial staging. | [56] |
Cryo | In cases with pagetoid spread, additional cryotherapy to the remaining conjunctiva is optional. The primary treatment is local resection if possible without extensive conjunctival resection. | |
Mitomycin-C | In cases with extensive conjunctival epithelial spread or residual conjunctival disease, topical Mitomycin- C could be considered as an alternative to extensive surgery or exenteration. If there is growth deep to the epithelium, Mitomycin-C is not an option. | |
Postoperative adjuvant radiation | Offer radiation for tumors staged T3 (AJCC 7-th edition) or more and in cases with perineural spread or insufficient margins. For patients who deny surgery, radiation at a sufficient dose could be considered. | |
Preoperative chemoreduction | In selected cases preoperative chemoreduction can be considered. | |
Follow-up | ||
The length of the follow-up | In minimum 5 years. 4) | |
Clinical follow-up interval | Follow-up interval is individual and depends on the post-diagnosis time-frame. In most cases four to 6 months follow-up interval can be considered. | – |
Follow-up examinations | The follow-up should in minimum comprise a clinical examination and palpation for lymph nodes. Patients should also be instructed to palpate the lymph nodes themselves in-between follow-ups. Annual scanning (ultrasound or MRI) for regional lymph node metastases is recommended. Scanning for distant metastases could be considered for category T2b (AJCC 7-th edition) or T2c (AJCC 8-th edition) or worse. |